1. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020) Authors: Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. Issue 1 (December 2016) Authors: Howard, Dena; Munir, Talha; Hockaday, Anna; Rawstron, Andy; Collett, Laura; Oughton, Jamie; Allsup, David; Bloor, Adrian; Phillips, David; Hillmen, Peter Journal: Trials Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chronic lymphocytic leukemia. Issue 4 (May 2015) Authors: Munir, Talha Journal: Hematology Issue: Volume 20:Issue 4(2015) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study. (24th May 2021) Authors: Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. (2nd August 2017) Authors: Varghese, Abraham M.; Rawstron, Andy; Newton, Darren; Tooze, Reuben M.; Munir, Talha; Dickson, Marion; Doody, Gina M.; Hillmen, Peter Journal: British journal of haematology Issue: Volume 182:Number 6(2018) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. Issue 5 (12th February 2022) Authors: Allsup, David John; Craig, Zoe; Cairns, David; Howard, Dena; Hockaday, Anna; Bloor, Adrian; Soe, Zarni; Pepper, Christopher; Gattei, Valter; Zucchetto, Antonella; Robbe, Pauline; Clifford, Ruth; Schuh, Anna; Munir, Talha; Rawstron, Andrew; Hillmen, Peter Journal: American journal of hematology Issue: Volume 97:Issue 5(2022) Page Start: E168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. (March 2017) Authors: Griffin, Morag; Munir, Talha Journal: Therapeutic advances in hematology Issue: Volume 8:Number 3(2017) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Microscopic observation drug susceptibility assay for the diagnosis of TB. Issue 10 (1st October 2007) Authors: Munir, Talha Journal: Thorax Issue: Volume 62:Issue 10(2007) Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Obinutuzumab as consolidation after chemo‐immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial. (26th August 2022) Authors: Munir, Talha; Emmerson, Jake; Hockaday, Anna; Oughton, Jamie B.; Howard, Dena; Phillips, David; Neilson, Jeff; Pemberton, Nicholas; Paneesha, Shankara; Kennedy, Ben; Rawstron, Andy; Hillmen, Peter Journal: British journal of haematology Issue: Volume 199:Number 5(2022) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P42 Use of trametinib, a MEK1 inhibitor, to treat Erdheim Chester disease (ECD). (20th April 2020) Authors: Alkoky, Hoda; Munir, Talha; Borg, Frances Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗